A Randomized, Cross-Over Controlled Trial of Dronabinol and Vaporized Cannabis in Neuropathic Low Back Pain

Trial Profile

A Randomized, Cross-Over Controlled Trial of Dronabinol and Vaporized Cannabis in Neuropathic Low Back Pain

Recruiting
Phase of Trial: Phase II

Latest Information Update: 21 Sep 2017

At a glance

  • Drugs Dronabinol (Primary) ; Marijuana
  • Indications Back pain; Neuropathic pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Sep 2016 Status changed from not yet recruiting to recruiting.
    • 26 Jul 2016 Planned initiation date changed from 1 Jun 2016 to 1 Sep 2016.
    • 04 Dec 2015 Planned End Date changed from 1 Feb 2019 to 1 May 2020 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top